Phibro Animal Health (PAHC) Non-Current Assets (2013 - 2026)
Phibro Animal Health (PAHC) posted quarterly Non-Current Assets of $551.0 million for Q1 2026, up 1.81% year-over-year from $541.2 million in Q1 2025, and up 1.41% quarter-over-quarter from $543.4 million in Q4 2025.
Phibro Animal Health (PAHC) Non-Current Assets (2013 - 2026) Analysis & Trends
Phibro Animal Health's Non-Current Assets history runs 14 years deep, the most recent figure standing at $551.0 million for Q1 2026.
- In Q1 2026, Non-Current Assets rose 1.81% year-over-year to $551.0 million; the TTM figure through Mar 2026 stood at $2.2 billion (up 18.15% YoY), while the FY2025 annual figure was $550.3 million, up 44.36% from the prior year.
- Non-Current Assets for Q1 2026 stood at $551.0 million, up from $543.4 million in the prior quarter.
- The five-year high for Non-Current Assets was $551.0 million in Q1 2026, with the low at $365.5 million in Q2 2022.
- The 5-year median for Non-Current Assets is $385.7 million (2023), against an average of $438.8 million.
- The sharpest annual moves came in 2024 and 2025: Non-Current Assets slipped 1.16% in 2024, then soared 44.36% in 2025.
- Phibro Animal Health's Non-Current Assets stood at $380.1 million in 2022, then increased by 1.57% to $386.1 million in 2023, then surged by 39.69% to $539.4 million in 2024, then increased by 0.74% to $543.4 million in 2025, then increased by 1.41% to $551.0 million in 2026.
- Business Quant data shows PAHC's Non-Current Assets at $551.0 million in Q1 2026, $543.4 million in Q4 2025, and $549.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 37.96 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 26.10 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 8.72 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 78.51 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 3.74 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 24.99 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 3.72 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 9.76 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 2.96 Bn |
| 10 | Phibro Animal Health | 1.42 Bn | 1.35 Bn | 125.68 Mn | 551.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 551.05 Mn |
| Dec 31, 2025 | 543.37 Mn |
| Sep 30, 2025 | 549.73 Mn |
| Jun 30, 2025 | 550.29 Mn |
| Mar 31, 2025 | 541.24 Mn |
| Dec 31, 2024 | 539.36 Mn |
| Sep 30, 2024 | 395.52 Mn |
| Jun 30, 2024 | 381.19 Mn |
| Mar 31, 2024 | 381.86 Mn |
| Dec 31, 2023 | 386.12 Mn |
| Sep 30, 2023 | 380.10 Mn |
| Jun 30, 2023 | 385.67 Mn |
| Mar 31, 2023 | 379.95 Mn |
| Dec 31, 2022 | 380.14 Mn |
| Sep 30, 2022 | 378.30 Mn |
| Jun 30, 2022 | 365.47 Mn |
| Mar 31, 2022 | 369.70 Mn |
| Dec 31, 2021 | 340.35 Mn |
| Sep 30, 2021 | 337.41 Mn |
| Jun 30, 2021 | 342.42 Mn |